Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Michael M. Cubrilo who wrote (488)	4/28/1998 7:52:00 PM
From: RBMac	Read Replies (1) \| Respond to of 1185

I hope this wasn't the news the market was anticipating or we are for another boxing day sale. Nortran Pharmaceuticals Inc. Announces Granting Of Incentive Stock Options To Employee Nortran Pharmaceuticals Inc. (VSE:NRT, NASD BB:NTRDF) announces the granting of incentive stock options, which, subject to VSE approval, will entitle an employee of the Company to purchase an aggregate of 150,000 common shares of the Company and are exercisable for 5 year period at a price of $2.37 per share. Nortran Pharmaceuticals Inc. is a drug discovery company focusing of pathology targeted small molecules. Nortran's current drugs in development target the ion channels responsible for life-threatening arrhythmias of the heart and for intractable pain. ON BEHALF OF THE BOARD ''Bob Rieder'' -------------- Robert W. Rieder Chief Executive Officer THE VANCOUVER STOCK EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.